Evidence map›Paper›PMID 40500630›Full record

ArticleTrends in molecular medicine2025

Psoriatic arthritis: diagnosis, pathogenesis, and emerging therapies.

Iannis E Adamopoulos, Xenofon Baraliakos, Christopher Ritchlin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Trends in molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CD200Nature communications · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Iannis E AdamopoulosDepartment of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: Iadamopo@bidmc.harvard.edu.
Xenofon BaraliakosRuhr-University Bochum, Rheumazentrum Ruhrgebiet Herne, Germany.
Christopher RitchlinDivision of Allergy, Immunology, and Rheumatology, Box 695, University of Rochester Medical Center, Rochester, NY 14643, USA.

Funding

The IL-23/IL-17 Axis in Inflammatory ArthritisR01AR062173 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEVY, DAN · 2012 to 2025
$4.9M
Cellular and Molecular Mechanisms of IL-17A in the Pathogenesis of Psoriatic ArthritisR01AR084848 · NIAMS · UNIVERSITY OF ARIZONA · PI Iannis Elias Adamopoulos · 2025 to 2026
$1.2M
NIAMS NIH HHS R01 AR062173NIAMS NIH HHS R01 AR084848
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

innate immunityinterleukin 17interleukin 23psoriatic arthritis

Identifiers

PMID40500630
PMCPMC12393800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.